Bio and Medicine
Bio & Medicine News – Nanobiology News, Nanomedicine News, Nanotech News, Nanotechnology News The latest science news on nanobiology, nano medicine, nanotechnology, nanoscience, and nanotech.
-
AI helps microscopes find the most informative nanoscale features in a sample
on September 13, 2026 at 8:00 pm
Researchers at the Department of Energy’s Oak Ridge National Laboratory (ORNL) have developed an artificial intelligence framework that helps researchers use atomic force microscopes to identify important nanoscale features while autonomously targeting the most informative areas of a sample for closer study.
-
Magnetic nanoparticles detect amoxicillin allergy with 98% sensitivity in early tests
on September 12, 2026 at 11:30 pm
A multidisciplinary scientific team at the University of Malaga has developed a new technology based on magnetic nanoparticles that enables precise, rapid and reliable diagnosis of allergy to beta-lactam antibiotics, including amoxicillin and other penicillins.
-
Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma
on September 10, 2026 at 4:40 pm
Glioblastoma is one of the most aggressive and treatment-resistant brain cancers known to medicine, carrying a median survival of just 12–15 months, even with the best available care.
-
Electrical fingerprint on tiny cell particles could offer new way to spot pancreatic cancer signals
on September 9, 2026 at 11:40 pm
An electrical fingerprint found on tiny particles in the blood may help detect signs of pancreatic cancer that are often overlooked, according to new research from Rice University. The researchers developed a device that separates these particles based on their electrical charge, making cancer-associated signals more visible.
-
Bacterial nanoplatform reprograms spleen immune cells to help prevent cancer recurrence
on September 3, 2026 at 4:00 pm
A research team led by Professor Yong Taik Lim at the SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University, have developed an engineered nanoplatform named t-SMC (trained immunity-mediated splenic myelopoiesis converter), which precisely targets the spleen to reverse splenic myelopoiesis toward an antitumoral immune phenotype. The research is published in the journal Advanced Materials.
